183 related articles for article (PubMed ID: 3151216)
1. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
Moya PR; Trombotto GT
Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
[No Abstract] [Full Text] [Related]
2. [Treatment of Chagas' disease].
Apt W
Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
[No Abstract] [Full Text] [Related]
3. [Allopurinol in the treatment of chronic Chagas' disease].
Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
[No Abstract] [Full Text] [Related]
4. Adverse events after the use of benznidazole in infants and children with Chagas disease.
Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
[TBL] [Abstract][Full Text] [Related]
5. Antitrypanosomal therapy for chronic Chagas' disease.
Bern C
N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
[No Abstract] [Full Text] [Related]
6. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
[TBL] [Abstract][Full Text] [Related]
7. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
Coura JR; de Abreu LL; Willcox HP; Petana W
Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337
[TBL] [Abstract][Full Text] [Related]
8. [Possibility of treatment in Chagas' disease].
Prata A
AMB Rev Assoc Med Bras; 1978 Apr; 24(4):140-2. PubMed ID: 98813
[No Abstract] [Full Text] [Related]
9. [Undesirable effects of nifurtimox and benznidazole].
Laplumé H; Barousse AP; Cabrera H
Medicina (B Aires); 1982; 42(2):223. PubMed ID: 7144529
[No Abstract] [Full Text] [Related]
10. Antitrypanosomal agents: treatment or threat?
Issa VS; Bocchi EA
Lancet; 2010 Sep; 376(9743):768; author reply 768-9. PubMed ID: 20816538
[No Abstract] [Full Text] [Related]
11. Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease).
Castro JA; Diaz de Toranzo EG
Biomed Environ Sci; 1988 Jun; 1(1):19-33. PubMed ID: 3151755
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.
Gallerano RH; Marr JJ; Sosa RR
Am J Trop Med Hyg; 1990 Aug; 43(2):159-66. PubMed ID: 2117857
[TBL] [Abstract][Full Text] [Related]
13. Contributions of toxicology to the problem of Chagas' disease (American Trypanosomiasis)--a year 2000 update.
Castro JA
Biomed Environ Sci; 2000 Dec; 13(4):271-9. PubMed ID: 11351860
[No Abstract] [Full Text] [Related]
14. Tolerance and safety of nifurtimox in patients with chronic chagas disease.
Jackson Y; Alirol E; Getaz L; Wolff H; Combescure C; Chappuis F
Clin Infect Dis; 2010 Nov; 51(10):e69-75. PubMed ID: 20932171
[TBL] [Abstract][Full Text] [Related]
15. Current status of Chagas disease chemotherapy.
Guedes PM; Silva GK; Gutierrez FR; Silva JS
Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease.
Jackson Y; Wyssa B; Chappuis F
J Antimicrob Chemother; 2020 Mar; 75(3):690-696. PubMed ID: 31754690
[TBL] [Abstract][Full Text] [Related]
17. Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.
Murcia L; Carrilero B; Albajar Viñas P; Segovia M
Rev Esp Quimioter; 2012 Mar; 25(1):74-5. PubMed ID: 22488545
[No Abstract] [Full Text] [Related]
18. [Nifurtimox, a bright future for treatment of Chagas disease].
Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
[TBL] [Abstract][Full Text] [Related]
19. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
[TBL] [Abstract][Full Text] [Related]
20. Should benznidazole be used in chronic Chagas' disease?
Bestetti RB
Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
